Emna Bakillah,Ari D Brooks,Seye Adekeye
Emna Bakillah
Introduction: Tumescent dissection (TUM) combines the use of crystalloid, local anesthetic, and epinephrine to create a bloodless plane to raise skin flaps. We aim to compare outcomes of TUM versus standard electrocautery dissection in mast...
Comparative Study
The breast journal. 2025 Jan 27:2025:7634729. DOI:10.1155/tbj/7634729 2025
The Risk of Haematoma and Venous Thrombosis Associated With Thromboprophylaxis Use in Breast Cancer Surgery: A Meta-Analysis and Systematic Review [0.03%]
乳腺癌手术中使用抗凝血药与发生血肿和静脉血栓的风险性：一项荟萃分析及系统综述
Amenah Dhannoon,Ishwarya Balasubramanian,Ali A Dhannoon et al.
Amenah Dhannoon et al.
Background: The routine use of venous thromboembolism (VTE) prophylaxis in breast cancer surgery has caused substantial polarity among breast cancer surgeons across the globe. The aim of this study is to assess the use of VTE prophylaxis in...
Management of Idiopathic Granulomatous Mastitis: Effectiveness of a Steroid-Free Regimen Using Tinospora cordifolia-A Single-Institution Experience [0.03%]
原发性肉芽肿性乳腺炎的治疗：单中心使用人心叶青藤草制定激素免用药方案的有效性研究
Ankita Das Sheth,Shalaka Joshi,Arul Kumar et al.
Ankita Das Sheth et al.
Introduction: Idiopathic granulomatous mastitis (IGM) is a benign, chronic inflammatory disease with no effective treatment and high relapse rate. The pathophysiology is poorly understood. Tinosporin, an immunomodulator obtained from Tinosp...
Intralesional Steroid Injections for Management of Granulomatous Mastitis: A Systematic Review of Treatment Protocols and Clinical Outcomes [0.03%]
肉芽肿性乳腺炎的病灶内皮质激素注射治疗：治疗方案和临床疗效的系统评价
J Vercoe,N Sedaghat,M E Brennan
J Vercoe
Introduction: Although idiopathic granulomatous mastitis (GM) of the breast is a benign condition, it can be locally aggressive and frequently chronic, causing significant pain and distress to the patient. Treatment often involves multiple ...
The Dynamic Changes of COL11A1 Expression During the Carcinogenesis and Development of Breast Cancer and as a Candidate Diagnostic and Prognostic Marker [0.03%]
COL11A1在乳腺癌发生发展过程中的动态变化及其作为潜在诊断和预后标志物的价值研究
Yuli Wang,Jing Wang
Yuli Wang
Purpose: Collagen type XI alpha 1 (COL11A1), a critical member of the collagen superfamily, is essential for tissue structure and integrity. This study aimed to validate previously identified variations in COL11A1 expression during breast c...
Evaluating YouTube Videos With Prophylactic Mastectomy Content in Terms of Their Quality and Reliability [0.03%]
从质量和可靠性角度评估含有预防性乳房切除内容的YouTube视频
Tansu Altintas,Mehlika Bilgi Kirmaci
Tansu Altintas
Aim: Purpose of this study is to investigate the quality and reliability of YouTube video contents on prophylactic mastectomy. Material and Methods: The search terms "prophylactic mastectomy," "prophylactic mastectomy surgery," "preventive ...
Relationship Between Mitochondrial Biological Function and Breast Cancer: An Approach Based on Mendelian Randomization Analysis [0.03%]
基于门德尔随机化分析的线粒体生物功能与乳腺癌的关系研究
Shichen Miao,Qichao Ni,Jun Fang
Shichen Miao
Objective: This study aims to investigate the potential causal link between mitochondrial function and breast cancer using the Mendelian randomization (MR) analysis. Methods: The data used for this study were obtained from genomewide associ...
Targeted Treatment of Metastatic Triple-Negative Breast Cancer: A Systematic Review [0.03%]
转移性三阴性乳腺癌的靶向治疗：系统评价研究
Anna Martha Hammershøi Madsen,Rikke Helene Løvendahl Eefsen,Dorte Nielsen et al.
Anna Martha Hammershøi Madsen et al.
Introduction: Triple-negative breast cancer (TNBC) is a subgroup of breast cancer characterized by the absence of estrogen and the human epidermal 2 receptor and also a lack of targeted therapy options. Chemotherapy has s...
The Effects of Anlotinib Combined with Chemotherapy following Progression on Cyclin-Dependent Kinase 4/6 Inhibitor in Hormone Receptor-Positive Metastatic Breast Cancer [0.03%]
阿帕替尼联合化疗治疗激素受体阳性转移性乳腺癌患者的疗效及CDK4/6抑制剂耐药后的疗效分析
Ting Xu,Weili Xiong,Lili Zhang et al.
Ting Xu et al.
Purpose: Endocrine therapy combined with cyclin-dependent kinase (CDK) 4/6 inhibitors (CDK4/6i) is the preferred treatment for hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) meta...
Upregulated SAE1 Drives Tumorigenesis and Is Associated with Poor Clinical Outcomes in Breast Cancer [0.03%]
乳腺癌中上调的SAE1驱动肿瘤发生并与临床结果差相关
Hong Liu,Jing Wang,Yunhai Li et al.
Hong Liu et al.
Background: The purpose of this study was to analyze SUMO activating enzyme subunit 1 (SAE1) expression in breast cancer (BC). Through bioinformatics analysis and in vitro experiments, the biological function and possibly...